Dr Andrew Stephens
Research Group Head
Centre for Cancer Research
Hudson Institute of Medical Research
Australia
Biography
After completing a PhD in the Department of Biochemistry at Monash University, Dr Andrew Stephens undertook a postdoctoral position at the University of Sydney using proteomics to discover novel antibiotic targets in bacteria. In 2006, he returned to Melbourne to establish a proteomics laboratory at the Hudson Institute, under the guidance of Professor David Robertson. In 2009, he established the Ovarian Cancer Biomarker group to specifically drive new research into the design and development of diagnostic tools, to improve the detection and management of ovarian cancers.
Research Interest
His work aims to better understand the development of ovarian tumours and identify specific biological events useful as markers of early-stage disease.
Publications
-
Stanton PG, Foo CFH, Rainczuk A, Stephens AN, Condina M, O’Donnell L, Weidner W, Ishikawa T, Cruickshanks L, Smith LB, McLachlan RI (2016) Mapping the testicular interstitial fluid proteome from normal rats. Proteomics 16:2391-402.
-
Heng S, Stephens AN, Jobling TW, Nie G (2016) Measuring PC activity in endocervical swab may provide a simple and non-invasive method to detect endometrial cancer in post-menopausal women. Oncotarget 7:46573-46578.
-
Heng S, Stephens AN, Jobling TW, Nie G (2016) Total PC activity is increased in uterine lavage of post-menopausal endometrial but not ovarian cancer patients. J Cancer 7:1812-1814.
